CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 45 enrolled
Drug / intervention
Bilateral erector spinae blocks using ropivacainedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04567407
NCT04567407Phase 4Completed
CompareCT.gov

Bilateral Continuous Erector Spinae Blocks for Post-Sternotomy Pain Management

Boston Children's Hospital·interventional·Posted Sep 28, 2020·Updated Oct 17, 2023

In Brief

A Phase 4 clinical trial evaluating Bilateral erector spinae blocks using ropivacaine for Postoperative Pain. Completed, enrolled 45 participants across 1 site.

Detailed Summary

To evaluate the efficacy of bilateral continuous erector spinae blocks (BESB) for postoperative analgesia in children and adolescents undergoing cardiac surgical procedures via sternotomy in the Early Recovery After Surgery (ERAS) program in a single arm, open label, interventional study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Pain
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
202120222023202420252026
First PostedSep 28, 2020
Enrollment StartSep 22, 2020
Primary CompletionJan 22, 2022
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 5.8 years ago

Interventions

Bilateral erector spinae blocks using ropivacainedrug

Bilateral chest wall nerve blocks using ropivacaine.